Pancreatic Cancer Research

ResearcherChongqing UniversityActive in the last 2 years

Gangyin Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9434-9251; OpenAlex author ID A5100416975. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

  1. DT-13 inhibits the proliferation of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling. Co-author DOI 10.1016/j.bbrc.2023.149451↗
  2. Periplocin Induces Apoptosis of Pancreatic Cancer Cells through Autophagy via the AMPK/mTOR Pathway. Co-author DOI 10.1155/2022/8055004↗
  3. Periplocin inhibits the growth of pancreatic cancer by inducing apoptosis via AMPK-mTOR signaling. Co-author DOI 10.1002/cam4.3611↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ziwei Li · 1 shared paper, 2024 · strength 0.28
  2. Linxiao Sun · 1 shared paper, 2021 · strength 0.19
  3. Bicheng Chen · 1 shared paper, 2021 · strength 0.19
  4. Jiawei Chen · 1 shared paper, 2022 · strength 0.16
  5. Bicheng Chen · 1 shared paper, 2022 · strength 0.16
  6. Lihong Yang · 1 shared paper, 2022 · strength 0.16
  7. Hewei Zhang · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.